Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.

NCT04818125 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT04818125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2021
Completion date
July 29, 2022
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer